Nov 3, 4:42 PM ET
On November 3, 2026, Procter & Gamble closed an underwritten public offering of four series of euro-denominated notes under its existing Form S-3 shelf registration, totaling €3.25 billion in principal. The notes mature between 2030 and 2046 and carry coupons from 3.750% to 4.625%, so the offering adds long-term debt to the company's balance sheet.
- Four tranches: €750 million due November 3, 2030 at 3.750%; €1.0 billion due November 3, 2034 at 4.100%; €750 million due November 3, 2038 at 4.250%; €750 million due November 3, 2046 at 4.625%
- Offering closed on November 3, 2026, under Registration No. 333-299472
- Legal opinions filed as Exhibits 5(a) and 5(b); the filing does not state the use of proceeds
Read the filing on SEC.gov ↗
Nov 2, 4:33 PM ET
On November 2, 2026, Procter & Gamble closed an underwritten public offering of $352,231,000 in aggregate principal amount of Floating Rate Notes due November 2, 2076, sold under its existing Form S-3 registration statement. The filing is administrative, attaching legal opinions for the notes and no new financial results or guidance.
- Offering closed November 2, 2026: $352,231,000 aggregate principal amount of Floating Rate Notes
- Notes mature November 2, 2076, under Registration No. 333-299472
- Filing attaches legal opinions (Exhibits 5(a) and 5(b)) and consents; no earnings or guidance included
Read the filing on SEC.gov ↗
Oct 30, 4:23 PM ET
Procter & Gamble closed an underwritten public offering of four series of notes totaling $4.0 billion on October 30, 2026, issued under its existing Form S-3 shelf registration. The filing discloses only the offering terms and attached legal opinions, and does not state the use of proceeds.
- $750 million of 5.125% notes due October 30, 2031, and $750 million of 5.300% notes due October 30, 2033
- $1.25 billion of 5.450% notes due October 30, 2036, and $1.25 billion of 5.900% notes due October 30, 2056
- Issued under Registration Statement on Form S-3 (Registration No. 333-299472)
- Legal opinions from Travonte Warren and Fried, Frank, Harris, Shriver & Jacobson LLP are filed as exhibits
Read the filing on SEC.gov ↗
Oct 22, 10:29 AM ET
Procter & Gamble reported first-quarter fiscal 2027 results for the period ended September 30, 2026, with organic sales up 4.0% and core EPS up 1% to $2.00. The company maintained its fiscal 2027 organic sales, core EPS and all-in EPS growth guidance and updated net sales growth guidance to +2% to +4%, while citing a $1.4 billion after-tax headwind from higher energy, transportation and raw material costs.
- Organic sales grew 4.0%, with volume up 2.4%, mix up 1.1% and pricing up 0.4%.
- Core EPS was $2.00, up 1%; currency-neutral core EPS was $1.99, in line with the prior year.
- Core gross margin fell 150 basis points to 50.0% and core operating margin fell 80 basis points to 25.9%.
- Fiscal 2027 guidance: core EPS growth of 0% to 3% and all-in EPS growth of 1% to 5%, both maintained; net sales growth of 2% to 4%, updated.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
